RBR-4vm3yy招募中未知
se of convalescent plasma submitted to pathogen inactivation for the treatment of patients with severe COVID-19
Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti0 个研究点开始时间: 2020年5月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •Age > or equal to 18 years; Severe or critical-19 COVID-19; Length of stay < 3 days; Laboratory confirmation of COVID-19 by detection of the viral genome in respiratory secretions, collected by swab; Signature, by the patient or a relative, of the informed consent form
排除标准
- •Allergic reactions prior to plasma transfusion
研究者
相似试验
招募中
不适用
Convalescent Plasma therapy for COVID-19 PatientsCOVID-19 Disease.COVID-19 DiseaseU07.02IRCT20200325046860N1Darmanara .Co200
招募中
3 期
Convalescent Plasma Therapy from Recovered Patients to Treat COVID-19 Early in SARS-CoV-2 DiseaseNL-OMON49795Erasmus MC, Universitair Medisch Centrum Rotterdam690
招募中
不适用
A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infectionsCOVID-19NL-OMON23835eiden University Medical Center430
招募中
不适用
Plasma therapy in patient with COVID-19IRCT20200416047099N1Shahid Beheshti University of Medical Sciences10
进行中（未招募）
2 期
se of plasma of cured person to treat patient with severe covid-19Coronavirus infection, transfusion, C23, A00-B99, Coronavirus OC43, Human.A00-B99RBR-7f4mt9fHemocentro de Ribeirão Preto